898 abstracts found.



Results filter



Models for delivery of follow-up care – what does the evidence tell us thus far?

Year:

Session type:

Jon Emery1,

1University of Melbourne, Melbourne, Australia




Optimising care beyond breast cancer – perspectives from the front line

Year:

Session type:

Alastair M Thompson1, Maggie Wilcox2,
1University of Texas MD Anderson Cancer Center, Houston, USA,2Independent Cancer Patients' Voice, London, UK



Wnt activating mechanisms in colorectal cancer

Year:

Session type:

Vivian Li1,
1Medical Research Council (MRC) National Institute for Medical Research, London, UK



Introduction: High precision radiation therapy

Year:

Session type:

Diana Tait1,
1The Royal Marsden NHS Foundation Trust and The Royal College of Radiologists, London, UK



Tumour-propagating cells in non-small cell lung cancer

Year:

Session type:

Carla Kim1,
1Children's Hospital Boston, Boston, USA



Stereotactic ablative radiotherapy (SABR): a local therapy poised to fight metastatic cancer

Year:

Session type:

Robert Timmerman1,
1University of Texas Southwestern Medical Center, Dallas, USA



What can we learn from circulating tumour cells in lung cancer – biomarkers, mouse models, drug resistance and heterogeneity

Year:

Session type:

Caroline Dive1,
1Cancer Research UK Manchester Institute, Manchester, UK



Neutral and biased replacement of intestinal stem cells

Year:

Session type:

Doug Winton1,
1Cancer Research UK Cambridge Institute, Cambridge, UK



Proton therapy: pushing the frontiers of radiotherapy

Year:

Session type:

Tony Lomax1,
1Centre for Proton Therapy, Paul Scherrer Institut, Villigen, Switzerland



Introduction: Inflammation and cancer

Year:

Session type:

Fran Balkwill1,
1Queen Mary, University of London, London, UK

Page 1 of 901...25...Last »